PP
Piramal Pharma
PPLPHARMA.NS·NSEMumbai INFounded 19886,000 employees
Small CappharmaPublicOncology
Platform: CDMO & OTC
Market Cap
$1.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (PPLPHARMA.NS)
Loading PPLPHARMA.NS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| PPL-6055 | PPL-6055 | Phase 2/3 | 2 | Nectin-4 | MigraineCRC | ||
| Mavuderotide | PPL-355 | Preclinical | 1 | CGRP | ObesityMM |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Piramal Pharma trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)